MacroGenics Inc (MGNX)
Healthcare
Biotechnology
3.80 $
+3.5%
vs. previous close
Closing price · As of: 3. Aug 2026
MacroGenics Inc (MGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -36 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.1 | -35 | -28 | -46 | -44 | 60 | -38 | -47 | -47 | -30 | 43 | -36 | -70 | |
| 2.8 | 2.0 | 1.9 | 1.8 | 1.8 | 1.8 | 2.1 | 1.8 | 1.9 | 1.8 | 1.6 | 1.7 | 6.9 | |
| 4.4 | 4.8 | 4.4 | 5.6 | 6.7 | 6.0 | 11 | 4.4 | 3.7 | 3.5 | 2.7 | 2.6 | 13 | |
| 4.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 33 | -11 | 13 | -0.1 | 3.0 | -4.1 | 2.6 | -12 | -17 | -52 | 53 | -1.8 | -18 | |
| 0.3 | 0.5 | 0.6 | 1.5 | 1.0 | 0.6 | 0.6 | 0.5 | 0.7 | 0.4 | 0.2 | 0.3 | 1.7 | |
| -113 | -34 | 39 | 25 | 47 | 36 | 41 | 9.9 | -38 | -20 | -66 | 45 | -79 | |
| 0.1 | – | 0.1 | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | -0.1 | 0.3 | – | – | – | – | -0.3 | – | – | – | – | – | |
| 0.1 | 50 | 0.3 | 0.2 | 0.6 | -0.1 | 0.2 | -0.3 | 70 | 0.0 | 0.1 | -0.2 | 70 | |
| -116 | -19 | 11 | -21 | 3.6 | 96 | 3.2 | -37 | -15 | -51 | -23 | 9.3 | -79 | |
| -2.4 | -36 | -29 | -47 | -46 | 60 | -39 | -47 | -48 | -31 | 43 | -36 | -72 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.